Cash Ratio Analysis of Akero Therapeutics Inc - Deep Dive


Cash Ratio of AKRO
Dec-23
28.75
Excellent Cash Ratio
Dec-22
18.42
Excellent Cash Ratio
Growth
56.13
%
Cash Ratio Analysis of Akero Therapeutics Inc
Cash Ratio of Akero Therapeutics Inc with value of 28.75 indicates that a company has generated more cash in a period than what is needed to pay off its current liabilities.
Cash Ratio of AKRO rose handsomely by 56.13 % this year.
Cash Ratio with value of 28.75 was highest in Year Dec-23 in last Five Years.
Cash Ratio with value of 7.49 was lowest in Year Dec-21 in last Five Years.
Latest Cash Ratio with value of 28.75 is Greater than Average Cash Ratio of 17.94 in last five years.
Other Cash Ratio Related Info of AKRO that may interest you.
Akero Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
AKRO22.9123.98 4.46 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents.   more ..
Cash Ratio Formula

Cash Ratio Related Ratios
CurrentRatioQuickRatioDebtToEquityRatio

Tsr Stability Index
No Significant Stability
FY - Historical Cash Ratio of Akero Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Cash Ratio28.7518.427.4920.4714.5632.442.69
Change56.13 %145.82 %-63.40 %40.61 %-55.12 %1104.30 %
FY Chart of Cash Ratio of Akero Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)